Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 2 feeds behind: Insider filings, 5 days, and 1 more · Every feed →

All 40Congress 0Executive branch 0Insiders 40
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

ELVN · $50K+ · 40 trades

Trades
40
Buys 0 · Sells 40
People
8
Stocks
1
Disclosed value
$168M
range midpoints · Congress & executive
Filed late
6
  1. ▼ SELLJ. Scott Garland DirectorELVN Enliven Therapeutics, Inc.$607Kdisclosed Oct 5 · filed 4 days after the trade
  2. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$146Kdisclosed Sep 21 · filed 4 days after the trade
  3. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$177Kdisclosed Sep 21 · filed 4 days after the trade
  4. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$111Kdisclosed Sep 21 · filed 4 days after the trade
  5. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$93.5Kdisclosed Sep 21 · filed 4 days after the trade
  6. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$228Kdisclosed Aug 19 · filed 2 days after the trade
  7. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$270Kdisclosed Aug 19 · filed 2 days after the trade
  8. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$65.3Kdisclosed Aug 19 · filed 2 days after the trade
  9. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$82.4Kdisclosed Aug 19 · filed 2 days after the trade
  10. ▼ SELLMika K Derynck DirectorELVN Enliven Therapeutics, Inc.$9.6Mdisclosed Aug 6 · filed 2 days after the trade
  11. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$134Kdisclosed Jul 21 · filed 4 days after the trade
  12. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$108Kdisclosed Jul 21 · filed 4 days after the trade
  13. ▼ SELLHelen Louise Collins Chief Medical OfficerELVN Enliven Therapeutics, Inc.$117Kdisclosed Jul 21 · filed 4 days after the trade
  14. ▼ SELLBenjamin Hohl Chief Financial OfficerELVN Enliven Therapeutics, Inc.$141Kdisclosed Jul 21 · filed 4 days after the trade
  15. ▼ SELLLori Anne Kunkel DirectorELVN Enliven Therapeutics, Inc.$205Kdisclosed Jul 8 · filed 2 days after the trade
  16. ▼ SELLLori Anne Kunkel DirectorELVN Enliven Therapeutics, Inc.$299Kdisclosed Jul 8 · filed 2 days after the trade
  17. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  18. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$66.5Kdisclosed Jun 24 · filed 2 days after the trade
  19. ▼ SELLOrbimed Advisors LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  20. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$2.1Mdisclosed Jun 24 · filed 2 days after the trade
  21. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$66.5Kdisclosed Jun 24 · filed 2 days after the trade
  22. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  23. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$66.5Kdisclosed Jun 24 · filed 2 days after the trade
  24. ▼ SELLOrbiMed Genesis GP LLC 10% ownerELVN Enliven Therapeutics, Inc.$1.1Mdisclosed Jun 24 · filed 2 days after the trade
  25. ▼ SELLOrbiMed Capital GP VII LLC 10% ownerELVN Enliven Therapeutics, Inc.$35.7Mdisclosed Jun 24 · filed 2 days after the trade